Quarterly
Annual
| Unit: USD | |
|---|---|
cash flows from operating activities: | |
net income from consolidated operations | |
adjustments to reconcile net income to net cash from operating activities: | |
depreciation and amortization | |
gain on disposal of assets | |
loss on disposal of assets | |
gain on sale of investments and technology investment income | |
loss on sale of investments and technology investment losses | |
reserve for credit losses | |
deferred income taxes | |
stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock | |
impairment charge | |
change in operating assets and liabilities: | |
accounts receivable | |
inventories | |
prepaid expenses and other | |
accounts payable | |
accrued liabilities, excluding dividends declared | |
net cash from operating activities | |
cash flows used for investing activities: | |
activity in investments: | |
sales proceeds | |
maturities and calls | |
purchases | |
plant and equipment additions | |
proceeds from sale of plant and equipment | |
acquisition of businesses, net of cash acquired | |
loans to technology investment partners | |
increase in other assets | |
net cash from investing activities | |
cash flows used for financing activities: | |
issuance of common stock from stock plan transactions | |
cash dividends paid | |
repurchases of common stock | |
net cash from financing activities | |
net decrease in cash, cash equivalents, and restricted cash | |
cash, cash equivalents, and restricted cash, beginning of period | |
cash, cash equivalents, and restricted cash, end of period | |
reconciliation of cash, cash equivalents and restricted cash to the unaudited condensed consolidated balance sheets: | |
cash and cash equivalents | |
restricted cash included in prepaid expenses and other | |
deferred tax expense | |
net increase in cash and cash equivalents | |
cash and cash equivalents, beginning of period | |
cash and cash equivalents, end of period | |
net income | |
(gain) on disposal of assets | |
(gain) on sale of investments and technology investment income | |
gain on sale of investments and equity method investment income | |
loss on sale of investments and equity method investment losses | |
stock based compensation expense related to employee stock options, employee stock purchases and restricted stock | |
impairment charges | |
accrued liabilities | |
net cash flows from operating activities | |
activity in available-for-sale securities: | |
voxx share purchases | |
purchase of technology investments | |
net increase in cash, cash equivalents, and restricted cash | |
cash, cash equivalents, and restricted cash, beginning of year | |
cash, cash equivalents, and restricted cash, end of year | |
supplemental cash flow data | |
non-cash investing and financing activities: | |
change in property and equipment in accounts payable and accrued expenses and other current liabilities | |
change in deferred income taxes | |
(gain) on sale of investments and equity method investment income | |
purchase of equity method investments | |
net cash (used for) from investing activities | |
proceeds from borrowings on credit agreement | |
repayment of borrowings on credit agreement | |
(gain) on sale of investments | |
loss on sale of investments | |
accrued liabilities, excluding dividends declared and short-term debt | |
net decrease in cash and cash equivalents | |
cash flows (used for) financing activities: | |
net cash (used for) financing activities | |
gain on sale of investments | |
cash and cash equivalents, beginning of year | |
cash and cash equivalents, end of year | |
cash flows (used for) from investing activities: | |
cash flows (used for) investing activities: | |
net cash (used for) investing activities | |
decrease in other assets | |
repayment of long-term debt | |
repayment of debt | |
cash flows from investing activities: | |
decrease (increase) in other assets | |
excess tax benefits from stock based compensation | |
excess tax benefits from stock-based compensation | |
cash flows from financing activities: | |
deferred financing costs | |
(increase) in other assets | |
financing costs paid | |
(gain) loss on disposal of assets | |
(gain)/loss on disposal of assets | |
(gain) loss on sale of investments | |
net cash from (provided by) financing activities | |
impairment loss on available-for-sale securities | |
increase in investments | |
cash and cash equivalents, | |
beginning of year | |
end of year | |
stock based compensation expense related to employee stock options,employee stock purchases and restricted stock | |
net increase(decrease) in cash and cash equivalents | |
adjustments to reconcile net income to net cash from operating activities- |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
